WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lori J. BraenderChief Legal Officer2026-03-1040,102$4.17
$167.35kSell
Melina CioffiSVP Regulatory Affairs2026-03-1025,311$4.17
$105.62kSell
Daniel BarberPresident and CEO2026-03-10180,677$4.17
$753.97kSell
A. Ernest Toth Jr.Chief Financial Officer2026-03-1058,254$4.17
$243.09kSell
Sherry KorczynskiChief Commercial Officer2026-03-1015,741$4.17
$65.69kSell
Cassie JungChief Operating Officer2026-03-1045,791$4.17
$191.09kSell
Peter E. BoydChief People Officer2026-03-1029,814$4.17
$124.41kSell
Melina CioffiSVP Regulatory Affairs2025-12-022,083$5.93
$12.35kSell
Cassie JungChief Operating Officer2025-10-1525,000$3.10
$77.58kBuy
Peter E. BoydSVP IT HR Communications2025-10-1510,000$7.00
$70.00kSell

1 of 3

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP8.04%9,810,958$41.21MInstitution
Blackrock Inc6.37%7,775,402$32.66MInstitution
Rtw Investments LP5.12%6,250,000$26.25MInstitution
Vanguard Group Inc4.83%5,892,334$24.75MInstitution
Ecor1 Capital LLC2.15%2,625,000$11.03MInstitution
Samsara Biocapital LLC2.05%2,500,000$10.50MInstitution
State Street Corp2.02%2,462,778$10.34MInstitution
Geode Capital Management LLC1.94%2,368,092$9.95MInstitution
Federated Hermes Inc1.67%2,032,822$8.54MInstitution
Douglas K. Bratton1.61%1,963,890$8.25MInsider

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST59.15%6.65%Net SellingNet Selling
KMDA9.32%0.00%
ETON59.26%33.42%Net SellingNet Buying
IRWD70.54%29.46%Net SellingNet Selling
EBS46.61%53.39%Net SellingNet Selling
View Top Pharmaceutical Stocks

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 59.15% institutional shareholders, 6.65% Aquestive Therapeutics insiders, and 34.20% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.61% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $8.39M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.